Alliance A222001: Oxybutynin Versus Placebo for the Treatment of Hot Flashes in Patients Receiving Androgen-Deprivation Therapy for Prostate Cancer.

Journal:

Journal of Clinical Oncology

Published:

2026-01-27

DOI:

10.1200/jco-25-01486

Affiliations:

18

Authors:

17

Go to article

Institutions	Authors	Share
Mayo Clinic, United States of America (USA)	5.000000	0.29
Sandra and Edward Meyer Cancer Center, United States of America (USA)	2.000000	0.12
Aspirus Health, United States of America (USA)	1.000000	0.06
Georgetown Lombardi Comprehensive Cancer Center, United States of America (USA)	1.000000	0.06
OSU Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James), United States of America (USA)	1.000000	0.06
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, United States of America (USA)	1.000000	0.06
University of Missouri Health Care, United States of America (USA)	1.000000	0.06
Yale University, United States of America (USA)	1.000000	0.06
Mayo Clinic's Campus in Florida, United States of America (USA)	1.000000	0.06
Gibbs Cancer Center and Research Institute, United States of America (USA)	0.500000	0.03
Spartanburg Regional Healthcare System, United States of America (USA)	0.500000	0.03
Southeast Clinical Oncology Research Consortium, United States of America (USA)	0.500000	0.03
Messino Cancer Centers, United States of America (USA)	0.500000	0.03
Alliance for Clinical Trials in Oncology, United States of America (USA)	0.500000	0.03
The University of Chicago (UChicago), United States of America (USA)	0.500000	0.03

Interested in Clinical Sciences?